Brain Low Grade Glioma — Trials

Brain Low Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00823459	Everolimus in Treating Patients With Recurrent Low-Grade Glioma	completed	Phase 2	58	Susan ChangOTHER	1	Jul 28, 2020	clinicaltrials
NCT01462695	Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma	completed	Phase 2	30	National Cancer Institute (NCI)NIH	3	Aug 27, 2015	clinicaltrials
NCT00112736	Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	completed	Phase 1 / Phase 2	69	National Cancer Institute (NCI)NIH	1	Jun 15, 2015	clinicaltrials
NCT00411619	Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Data updated 22 days agoSource updated Jul 28, 2020source: clinicaltrials